Morrison Scott W
- SEC CIK
- 0001662426
No open-market purchases or sales filed in the past year.
Current role at each company
- TARS Tarsus Pharmaceuticals, Inc.Directoras of Jun 29, 2026
- ZLAB Zai Lab LtdDirectoras of Jun 22, 2026
- IDYA IDEAYA Biosciences, Inc.Directoras of Jun 18, 2026
- VERA Vera Therapeutics, Inc.Directoras of May 26, 2026
- CRVS Corvus Pharmaceuticals, Inc.Directoras of Jun 16, 2025
Show 1 more company
- GBT Global Blood Therapeutics, Inc.Directoras of Oct 6, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Morrison Scott W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZLAB Zai Lab Ltd
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2025 (view filing) | May 9 | 4 days | Morrison Scott WDirector | SSaleAmerican Depositary Shares | −23.8K | $30.05 | −$715.2K | −50.1%23.7K after |
GBT Global Blood Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 (view filing) | Sep 9 | 1 day | Morrison Scott WDirector | SSale | −4.80K | $30.21 | −$145.0K | −61.2%3.04K after |